Studies on the synthesis and anti-Osteoporosis of estrogen-GHRPs linkers

Bioorg Med Chem Lett. 2003 Jan 6;13(1):143-6. doi: 10.1016/s0960-894x(02)00847-8.

Abstract

The linkers of estrogen-GHRPs were prepared by the combination of estradiol, estrone, TyrGlyGlyPheLeuOH, and TyrGlyGlyPheLeuOH. Their anti-osteoporosis effect was evaluated by analyzing the data, for instance the weight of the body, femur, femur ash, the content of calcium and phosphor in the femur, the content of calcium and ALP activity in the serum, obtained from the corresponding bioassay in vivo. The results indicated that the anti-osteoporosis potency for estradiol, estrone, TyrGlyGlyPheLeuOH and TyrGlyGlyPheLeuNH(2) may be totally enhanced each other via the corresponding linkers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Calcium / analysis
  • Calcium / blood
  • Cross-Linking Reagents
  • Estrogens / chemistry*
  • Estrogens / pharmacology
  • Femur / chemistry
  • Femur / drug effects
  • Growth Hormone-Releasing Hormone
  • Hormones / chemical synthesis*
  • Hormones / pharmacology
  • Male
  • Oligopeptides / chemistry*
  • Oligopeptides / pharmacology
  • Osteoporosis / drug therapy*
  • Phosphorus / analysis
  • Rats

Substances

  • Cross-Linking Reagents
  • Estrogens
  • Hormones
  • Oligopeptides
  • Phosphorus
  • Growth Hormone-Releasing Hormone
  • Calcium